Inotiv

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery Through Multi-Omics Platform Integration

- Inotiv, a leading contract research organization, has announced a strategic collaboration with VUGENE to integrate AI-driven bioinformatics capabilities into its Discovery & Translational Sciences Division. - The partnership will enable more efficient analysis of complex biological datasets including epigenomic, proteomic, and molecular data to improve drug efficacy and safety predictions. - VUGENE's cloud-based platform combines multi-omics data analysis with machine learning solutions to accelerate scientific breakthroughs in biomedical research. - The collaboration aims to help pharmaceutical clients make faster, more informed decisions during early-stage drug discovery and development processes.